The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation: Original article

European Journal of Cancer Care

Volumn 18, Issue 5, 2009, Pages 477-482

  Maaskant, J M ^a   De Boer, J P ^a   Dalesio, O ^a   Holtkamp, M J ^a   Lucas, C ^b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Catheter related colonization; Central venous catheter; Infection; Neutropenia; Peripheral stem cell transplantation

Indexed keywords

BIOMATERIAL; CHLORHEXIDINE; SULFADIAZINE SILVER; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INDWELLING CATHETER; MALE; MIDDLE AGED; NEOPLASM; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS, LOCAL; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; DRUG COMBINATIONS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SILVER SULFADIAZINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69149083820     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00964.x     Document Type: Article

References (23)

1. Arnow P.M., Quimosing E.B. Beach M. (1993) Consequences of intravascular catheter sepsis. Clinical Infectious Diseases 16, 778 784.
2. Bach A., Schmidt H., Bottiger B., Schreiber B., Bohrer H., Motsch J., Martin E. Sonntag H.G. (1996) Retention of antibacterial activity and bacterial colonization of anti-septic bonded central venous catheters. Journal of Antimicrobial Chemotherapy 37, 315 322.
3. Ciresi D.L., Albrecht R.M., Volkers P.A. Scholten D.J. (1996) Failure of anti-septic bonding to prevent central venous catheter-related infection and sepsis. American Surgeon 62, 641 646.
4. Collin G.R. (1999) Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 115, 1632 1640.
5. George S.J., Vuddamalay P. Boscoe M.J. (1997) Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. European Journal of Anaesthesiology 14, 428 431.
6. Gnass S.A., Barboza L., Bilicich D., Angeloro P., Treiyer W., Grenovero S. Basualdo J. (2004) Prevention of central venous catheter-related bloodstream infections using non-technologic strategies. Infection Control and Hospital Epidemiology 25, 675 677.
7. Heard S.O., Wagle M., Vijayakumar E., McLean S., Brueggemann A., Napolitano L.M., Edwards L.P., O'Connell F.M., Puyana J.C. Doern G.V. (1998) Influence of triple-lumen central venous catheters coated with clorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Archives of Internal Medicine 158, 81 87.
8. Jaeger K., Zenz S., Juttner B., Ruschulte H., Kuse E., Heine J., Piepenbrock S., Ganser A. Karthaus M. (2005) Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Annals of Hematology 84, 258 262.
9. McGee D.C. Gould M.K. (2003) Preventing complications of central venous catheterization. The New England Journal of Medicine 348, 1123 1133.
10. Maki D.G., Ringer M. Alvarado C.J. (1991) Prospective randomised trial of povidon-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 328, 329 343.
11. Maki D.G., Stolz S.M., Wheeler S. Mermel L.A. (1997) Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Annals of Internal Medicine 127, 257 266.
12. Merrer J., De Jonghe B., Golliot F., Lefrant J-Y., Raffy B., Barre E., Rigaud J-P., Casciani D., Misset B., Bosquet C., Outin H., Brun-Buisson C. Nitenberg G. (2001) Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. Journal of the American Medical Association 286, 700 707.
13. Mimoz O., Pieroni L., Lawrence C., Edouard A., Costa Y., Samii K. Brun-Buisson C. (1996) Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Critical Care Medicine 24, 1818 1823.
14. Nador G., Nosari A., De Gasperi A., Marbello L., Nichelatti M., Corti A., Mancini V., Molteni A., Barate C., Ricci F., Ciapanna D., Garrone F., Ravelli E., Greco A., Turrini M. Morra E. (2006) Infectious complications in haematological patients with central venous catheters: a prospective analysis of risk factors and etiological agents. Haematologica 91 (Suppl. 1).
15. Ostendorf T., Meinhold A., Harter C., Salwender H., Egerer G., Geiss H.K., Antony D.Ho. Goldschmidt H. (2005) Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients - a double-blind, randomised, prospective, controlled trial. Supportive Care in Cancer 13, 993 1000.
16. Pittet D., Tarara D. Wenzel R.P. (1994) Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs and attributable mortality. Journal of the American Medical Association 271, 1598 1601.
17. Raad I., Darouiche R., Dupuis J., Abi-Said D., Gabrielli A., Hachem R., Wall M., Harris R., Jones J., Buzaid A., Robertson C., Shenaq S., Curling P., Burke T., Ericsson C. Study G. (1997) Central venous catheters coated with minocycline and rifampicin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Annals of Internal Medicine 127, 267 274.
18. Raad I.I., Hohn D.C., Gilbreath B.J., Suleiman N., Hill L.A., Bruso P.A., Marts K., Mansfield P.F. Bodey G.P. (1994) Prevention of central-venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 15, 231 238.
19. Richards B., Chaboyer W., Bladen T. Schluter P.J. (2003) Effect of central venous catheter type on infections: a prospective clinical trial. Journal of Hospital Infection 54, 10 17.
20. Richards M.J., Edwards J.R., Culver D.H. Gaynes R.P. (1999) Nosocomial infections in medical intensive care units in the United States. Critical Care Medicine 27, 887 892.
21. Tacconelli E., Tumbarello M., Pittiruti M., Leone F., Lucia M.B., Cauda R. Ortona L. (1997) Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. European Journal of Clinical Microbiology and Infectious Diseases 16, 203 209.
22. Traore O., Liotier J. Souweine B. (2005) Prospective study of arterial and central venous catheter colonization and of arterial- and central venous catheter-related bacteremia in intensive care units. Critical Care Medicine 33, 1276 1280.
23. Veenstra D.L., Saint S., Saha S., Lumley T. Sullivan S.D. (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. Journal of the American Medical Association 281, 261 267. (Pubitemid 29058116)